Sonova Holding (OTCMKTS:SONVY) Given Consensus Recommendation of “Hold” by Analysts

Sonova Holding (OTCMKTS:SONVY) has been given a consensus rating of “Hold” by the seven ratings firms that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company.

Several equities research analysts recently issued reports on SONVY shares. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Citigroup restated a “sell” rating on shares of Sonova in a research report on Wednesday, May 13th. Finally, Jefferies Financial Group cut Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday, March 18th.

Sonova Stock Performance

OTCMKTS SONVY opened at $51.62 on Wednesday. Sonova has a fifty-two week low of $42.26 and a fifty-two week high of $63.63. The stock’s fifty day moving average is $47.75 and its two-hundred day moving average is $49.93. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.75 and a quick ratio of 0.91.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.